The Effect of Police Body-Worn Cameras on Use of Force and Citizens’ Complaints Against the Police: A Randomized Controlled Trial
Abstract
AbstractObjectivePolice use-of-force continues to be a major source of international concern, inviting interest from academics and practitioners alike. Whether justified or unnecessary/excessive, the exercise of power by the police can potentially tarnish their relationship with the community. Police misconduct can translate into complaints against the police, which carry large economic and social costs. The question we try to answer is: do body-worn-cameras reduce the prevalence of use-of-force and/or citizens’ complaints against the police?MethodsWe empirically tested the use of body-worn-cameras by measuring the effect of videotaping police–public encounters on incidents of police use-of-force and complaints, in randomized-controlled settings. Over 12 months, we randomly-assigned officers to “experimental-shifts” during which they were equipped with body-worn HD cameras that recorded all contacts with the public and to “control-shifts” without the cameras (n = 988). We nominally defined use-of-force, both unnecessary/excessive and reasonable, as a non-desirable response in police–public encounters. We estimate the causal effect of the use of body-worn-videos on the two outcome variables using both between-group differences using a Poisson regression model as well as before-after estimates using interrupted time-series analyses.
ResultsWe found that the likelihood of force being used in control conditions were roughly twice those in experimental conditions. Similarly, a…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 988 participants or records.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.